XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Oct. 31, 2023
Cash flows from operating activities:      
Net income $ 63,865 $ 242,008 $ 205,891
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 13,863 7,730 8,798
Stock-based compensation 16,671 25,269 14,227
(Accretion) amortization of debt discounts, premiums and debt issuance costs (1,377) (1,041) 1,645
Gain on sale of property and assets (535) (1,143) (1,106)
Gain on consolidation of joint ventures (18,856) (45,653) (19,102)
Gain on inventory contributed to joint venture (22,682) 0 0
Income from unconsolidated joint ventures (46,437) (52,262) (43,160)
Distributions of earnings from unconsolidated joint ventures 4,408 3,919 18,650
Loss (gain) on extinguishment of debt 33,113 (1,371) 25,638
Noncontrolling interest in consolidated joint ventures 0 0 38
Inventory impairments and land option write-offs 39,571 11,556 1,536
Decrease (increase) in assets:      
Inventories 91,643 (183,522) 278,672
Receivables, deposits and notes 5,513 (11,901) 11,296
Origination of mortgage loans (1,761,425) (1,567,961) (1,216,923)
Sale of mortgage loans 1,798,719 1,549,272 1,197,988
Deferred tax assets 11,447 61,769 41,960
(Decrease) increase in liabilities:      
Accounts payable, accrued interest and other liabilities (36,401) (349) (59,554)
Customers’ deposits 2,436 (16,298) (29,913)
State income tax payable (5,257) 3,618 (1,306)
Net cash provided by operating activities 188,279 23,640 435,275
Cash flows from investing activities:      
Proceeds from sale of property and assets 1,806 1,419 1,961
Purchase of property, equipment, and other fixed assets (22,097) (17,859) (18,821)
Investment in and advances to unconsolidated joint ventures, net of reimbursements (50,216) (34,436) (77,822)
Distributions of capital from unconsolidated joint ventures 4,500 4,404 16,447
Net cash used in investing activities (66,007) (46,472) (78,235)
Cash flows from financing activities:      
Proceeds from mortgages and notes 164,762 301,017 324,849
Payments related to mortgages and notes (230,101) (340,093) (382,933)
Proceeds from model sale leaseback financing programs 51,579 27,136 12,412
Payments related to model sale leaseback financing programs (21,379) (22,564) (21,875)
Proceeds from land bank financing programs 186,643 98,735 53,115
Payments related to land bank financing programs (110,713) (86,624) (123,109)
Net proceeds (payments) related to mortgage warehouse lines of credit (37,054) 20,643 16,432
Proceeds from issuance of unsecured and senior secured notes 900,000 0 640,925
Payments related to senior and senior secured notes, senior secured term loans and senior unsecured term loans (906,920) (145,000) (752,182)
Preferred dividends paid (10,675) (10,675) (10,675)
Treasury stock purchases (30,244) (26,528) (4,800)
Debt issuance costs from note issuances, land banking financing programs and model sale leaseback financing programs (26,284) (3,973) (13,870)
Net cash used in financing activities (70,386) (187,926) (261,711)
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents 51,886 (210,758) 95,329
Cash and cash equivalents, and restricted cash and cash equivalents balance, beginning of period 266,761 477,519 382,190
Cash and cash equivalents, and restricted cash and cash equivalents balance, end of period 318,647 266,761 477,519
Supplemental disclosures of cash flows:      
Interest, net of capitalized interest (see Note 3 to the Consolidated Financial Statements) 45,415 47,803 62,576
Income taxes 16,033 9,694 9,407
Cash and cash equivalents, and restricted cash and cash equivalents balance, end of period 318,647 266,761 477,519
Home Building [Member]      
Supplemental disclosures of cash flows:      
Cash and cash equivalents 272,772 209,976 434,119
Restricted cash and cash equivalents 12,608 7,875 8,431
Financial Services [Member]      
Supplemental disclosures of cash flows:      
Cash and cash equivalents 5,548 6,589 4,519
Restricted cash and cash equivalents $ 27,719 $ 42,321 $ 30,450